Human Cells anti-COVID-19 S-IgA Neutralizing Antibody
Product Specifications
Background
Human monoclonal neutralizing antibody to COVID-19 S protein
CAS Number
9007-83-4
Synonyms
Spike glycoprotein; S glycoprotein; E2; Peplomer protein
Host
Human Cells
Reactivity
COVID-19
Clonality
Monoclonal
Applications
E
Purification Method
>95%, cultured in vitro under conditions free from animal derived components.
Concentration
1mg/mL
Dilution
ELISA: Use at an assay dependent dilution.
Buffer
1 mg/ml. Human IgA. Liquid in 0.01M Phosphate Buffered Saline, pH 7.4.
Storage Conditions
Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
WB Description
Immobilized Recombinant COVID-19 S Protein RBD-SD1 (Cat#CRP3097) at 5 ug/ml can bind Anti-COVID-19 S-IgA Neutralizing Antibody, the EC50 is less than 416 ng/ml.
IHC description
Anti-COVID-19 S-IgA Neutralizing Antibody can block Recombinant Human ACE2 Protein (Cat#CRP1003) and Recombinant COVID-19 S Protein RBD-SD1 (Cat#CRP3097) interaction, the IC50 for this effect is 19.8 ng/ml.
Gene ID (Human)
43740568
SwissProt (Human)
P0DTC2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC681820-500 1x 500 µL
Ep-CAM / CD326 (Epithelial Marker) (rVU-1D9), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740270-100 1x 100 µL
Fibronectin (HFN7.1), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040806-500 1x 500 µL
TYRP1 (Tyrosinase Related Protein 1) (TA99), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940225-100 1x 100 µL
Major Vault Protein (MVP) (1032), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details